| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Daniel D. Long | SVP Drug Discovery | 2025-11-10 | 3,501 | $18.06 | $63.22kSell |
| Uwe Klein | SVP Biological Sciences | 2025-08-18 | 4,935 | $2.76 | $13.62kBuy |
| Uwe Klein | SVP Biological Sciences | 2025-08-18 | 10,452 | $2.76 | $28.85kBuy |
| Uwe Klein | SVP Biological Sciences | 2025-08-18 | 7,621 | $6.81 | $51.90kBuy |
| Jeffrey Finer | CEO and President | 2025-04-03 | 5,000 | $2.76 | $13.80kBuy |
| Jeffrey Finer | CEO and President | 2025-04-02 | 50,000 | $2.76 | $138.00kBuy |
| Alan Ezekowitz | Director | 2025-03-07 | 13,319 | $6.93 | $92.27kBuy |
| Alan Ezekowitz | Director | 2025-03-06 | 41,355 | $6.00 | $248.13kBuy |
| Alan Ezekowitz | Director | 2025-03-05 | 37,835 | $5.82 | $220.28kBuy |
| Alan Ezekowitz | Director | 2025-03-04 | 7,491 | $6.35 | $47.55kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Third Rock Ventures VI LP | 23.29% | 10,427,250 | $288.00M | Insider |
| Third Rock Ventures V LP | 20.92% | 9,368,047 | $258.75M | Insider |
| Ra Capital Management LP | 15.62% | 6,995,858 | $193.23M | Institution |
| Trv GP V LLC | 13.88% | 6,215,591 | $171.67M | Institution |
| Driehaus Capital Management LLC | 10.99% | 4,919,896 | $135.89M | Institution |
| Trv GP VI LLC | 9.41% | 4,211,659 | $116.33M | Institution |
| Bvf Inc | 8.97% | 4,015,790 | $110.92M | Institution |
| Samsara Biocapital LLC | 7.03% | 3,149,128 | $86.98M | Institution |
| Siren LLC | 4.92% | 2,202,514 | $60.83M | Institution |
| Vanguard Group Inc | 3.39% | 1,518,757 | $41.95M | Institution |